MX2007008137A - Triazoloftalazinas como inhibidores de pde2. - Google Patents
Triazoloftalazinas como inhibidores de pde2.Info
- Publication number
- MX2007008137A MX2007008137A MX2007008137A MX2007008137A MX2007008137A MX 2007008137 A MX2007008137 A MX 2007008137A MX 2007008137 A MX2007008137 A MX 2007008137A MX 2007008137 A MX2007008137 A MX 2007008137A MX 2007008137 A MX2007008137 A MX 2007008137A
- Authority
- MX
- Mexico
- Prior art keywords
- triazolophthalazines
- meanings
- compounds
- formula
- given
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Los compuestos de la formula (I) en la cual R1 y R2 tienen los significados como se dan en la descripcion son inhibidores novedosos de PDE2 efectivos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05100045 | 2005-01-05 | ||
EP05100044 | 2005-01-05 | ||
PCT/EP2006/050041 WO2006072615A2 (en) | 2005-01-05 | 2006-01-04 | Triazolophthalazines as pde2-inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007008137A true MX2007008137A (es) | 2007-07-19 |
Family
ID=36604687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007008137A MX2007008137A (es) | 2005-01-05 | 2006-01-04 | Triazoloftalazinas como inhibidores de pde2. |
Country Status (16)
Country | Link |
---|---|
US (1) | US8106047B2 (es) |
EP (1) | EP1836207B1 (es) |
JP (1) | JP5240899B2 (es) |
KR (1) | KR20070095986A (es) |
CN (1) | CN101103033B (es) |
AU (1) | AU2006204454B2 (es) |
BR (1) | BRPI0606379A2 (es) |
CA (1) | CA2592007C (es) |
EA (1) | EA012505B1 (es) |
ES (1) | ES2397080T3 (es) |
HK (1) | HK1116776A1 (es) |
IL (1) | IL183919A (es) |
MX (1) | MX2007008137A (es) |
NO (1) | NO20073921L (es) |
NZ (1) | NZ555661A (es) |
WO (1) | WO2006072615A2 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2578368C (en) * | 2004-09-02 | 2013-07-02 | Altana Pharma Ag | Triazolophthalazines |
NZ555661A (en) | 2005-01-05 | 2010-11-26 | Nycomed Gmbh | Triazolophthalazines as PDE2-inhibitors |
CA2591991C (en) * | 2005-01-05 | 2013-11-19 | Altana Pharma Ag | Triazolophthalazines |
KR20120111739A (ko) | 2009-12-31 | 2012-10-10 | 센트로 내셔널 드 인베스티가시오네스 온콜로지카스 (씨엔아이오) | 키나제 억제제로서의 사용을 위한 삼환식 화합물 |
US9540379B2 (en) | 2011-01-31 | 2017-01-10 | Boehringer Ingelheim International Gmbh | (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases |
JP2014516074A (ja) * | 2011-06-07 | 2014-07-07 | ファイザー・インク | ピラゾロ[3,4−d]ピリミジン化合物ならびにそのPDE2阻害剤および/またはCYP3A4阻害剤としての使用 |
PE20142258A1 (es) | 2012-04-25 | 2015-01-15 | Takeda Pharmaceutical | Compuesto heterociclico nitrogenado |
US9187484B2 (en) | 2012-05-02 | 2015-11-17 | Southern Research Institute | Triazolopyridazine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof |
US9527841B2 (en) | 2012-07-13 | 2016-12-27 | Takeda Pharmaceutical Company Limited | Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors |
US20140045856A1 (en) | 2012-07-31 | 2014-02-13 | Boehringer Ingelheim International Gmbh | 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes |
EP2975031A4 (en) | 2013-03-14 | 2017-04-19 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
US10053468B2 (en) | 2013-07-03 | 2018-08-21 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
WO2015002230A1 (ja) | 2013-07-03 | 2015-01-08 | 武田薬品工業株式会社 | アミド化合物 |
JP6696904B2 (ja) | 2014-01-08 | 2020-05-20 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 製剤および医薬組成物 |
CN103694244B (zh) * | 2014-01-09 | 2016-03-30 | 郑州大学 | 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途 |
PT3597649T (pt) | 2014-04-23 | 2022-01-21 | Dart Neuroscience Llc | Composições contendo compostos substituidos de [1,2,4]triazolo[1,5-a] pirimidin-7il como inibidores de pde2 |
TWI568737B (zh) | 2014-11-05 | 2017-02-01 | 達特神經科學(開曼)有限責任公司 | 作為pde2抑制劑之經取代的5-甲基-[1,2,4]***并[1,5-a]嘧啶-2-胺化合物 |
JP6608934B2 (ja) | 2014-12-06 | 2019-11-20 | イントラ−セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
JP6608933B2 (ja) | 2014-12-06 | 2019-11-20 | イントラ−セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
WO2016145614A1 (en) * | 2015-03-17 | 2016-09-22 | Merck Sharp & Dohme Corp. | Triazolyl pyrimidinone compounds as pde2 inhibitors |
EP3285581B1 (en) | 2015-03-26 | 2021-08-11 | Merck Sharp & Dohme Corp. | Pyrazolyl pyrimidinone compounds as pde2 inhibitors |
US10195201B2 (en) | 2015-05-05 | 2019-02-05 | Merck Sharp & Dohme Corp. | Heteroaryl-pyrimidinone compounds as PDE2 inhibitors |
WO2016183741A1 (en) | 2015-05-15 | 2016-11-24 | Merck Sharp & Dohme Corp. | Pyrimidinone amide compounds as pde2 inhibitors |
WO2016191935A1 (en) | 2015-05-29 | 2016-12-08 | Merck Sharp & Dohme Corp. | 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors |
WO2016192083A1 (en) | 2015-06-04 | 2016-12-08 | Merck Sharp & Dohme Corp. | Dihydropyrazolopyrimidinone compounds as pde2 inhibitors |
WO2016209749A1 (en) | 2015-06-25 | 2016-12-29 | Merck Sharp & Dohme Corp. | Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors |
WO2017000276A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Bicyclic heterocyclic compounds as pde2 inhibitors |
WO2017000277A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Substituted triazolo bicycliccompounds as pde2 inhibitors |
EP3156405A1 (en) | 2015-10-13 | 2017-04-19 | Boehringer Ingelheim International GmbH | Spirocyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxamide |
JP2021504466A (ja) | 2017-11-23 | 2021-02-15 | オスロ ウニヴェルシティ ホスピタル ホーエフ | 頻脈の治療 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH21834A (en) * | 1982-01-18 | 1988-03-17 | Lepetit Spa | New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives |
IT1194310B (it) * | 1983-07-12 | 1988-09-14 | Lepetit Spa | Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti |
US5869486A (en) | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
YU2899A (sh) | 1996-07-25 | 2000-03-21 | Merck Sharp & Dohme Limited | Supstituisani triazolo-piridazin derivati kao ligandi za gaba receptore |
CA2288789C (en) | 1997-05-08 | 2009-07-21 | Merck Sharp & Dohme Limited | Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
US6235741B1 (en) * | 1997-05-30 | 2001-05-22 | Merck & Co., Inc. | Angiogenesis inhibitors |
GB9715977D0 (en) * | 1997-07-29 | 1997-10-01 | Merck Sharp & Dohme | Therapeutic agents |
IT1303272B1 (it) | 1998-10-29 | 2000-11-06 | Zambon Spa | Derivati triciclici inibitori della fosfodiesterasi 4 |
EP1261609B1 (de) | 1999-12-24 | 2004-11-03 | Bayer HealthCare AG | Triazolotriazinone und ihre verwendung |
GB0028583D0 (en) * | 2000-11-23 | 2001-01-10 | Merck Sharp & Dohme | Therapeutic compounds |
WO2002083140A1 (en) * | 2001-04-10 | 2002-10-24 | Merck & Co., Inc. | Inhibitors of akt activity |
EP1545533A1 (en) | 2002-09-04 | 2005-06-29 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US20070179161A1 (en) | 2003-03-31 | 2007-08-02 | Vernalis (Cambridge) Limited. | Pyrazolopyrimidine compounds and their use in medicine |
CA2578368C (en) * | 2004-09-02 | 2013-07-02 | Altana Pharma Ag | Triazolophthalazines |
CA2591991C (en) | 2005-01-05 | 2013-11-19 | Altana Pharma Ag | Triazolophthalazines |
NZ555661A (en) | 2005-01-05 | 2010-11-26 | Nycomed Gmbh | Triazolophthalazines as PDE2-inhibitors |
-
2006
- 2006-01-04 NZ NZ555661A patent/NZ555661A/en not_active IP Right Cessation
- 2006-01-04 EA EA200701396A patent/EA012505B1/ru not_active IP Right Cessation
- 2006-01-04 US US11/794,145 patent/US8106047B2/en not_active Expired - Fee Related
- 2006-01-04 MX MX2007008137A patent/MX2007008137A/es active IP Right Grant
- 2006-01-04 EP EP06700240A patent/EP1836207B1/en active Active
- 2006-01-04 ES ES06700240T patent/ES2397080T3/es active Active
- 2006-01-04 CA CA2592007A patent/CA2592007C/en not_active Expired - Fee Related
- 2006-01-04 BR BRPI0606379-9A patent/BRPI0606379A2/pt not_active IP Right Cessation
- 2006-01-04 CN CN2006800017646A patent/CN101103033B/zh not_active Expired - Fee Related
- 2006-01-04 WO PCT/EP2006/050041 patent/WO2006072615A2/en active Application Filing
- 2006-01-04 JP JP2007548843A patent/JP5240899B2/ja not_active Expired - Fee Related
- 2006-01-04 KR KR1020077017407A patent/KR20070095986A/ko not_active Application Discontinuation
- 2006-01-04 AU AU2006204454A patent/AU2006204454B2/en not_active Ceased
-
2007
- 2007-06-14 IL IL183919A patent/IL183919A/en not_active IP Right Cessation
- 2007-07-26 NO NO20073921A patent/NO20073921L/no not_active Application Discontinuation
-
2008
- 2008-06-30 HK HK08107251.1A patent/HK1116776A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101103033B (zh) | 2010-08-04 |
BRPI0606379A2 (pt) | 2009-06-23 |
HK1116776A1 (en) | 2009-01-02 |
WO2006072615A3 (en) | 2007-01-04 |
KR20070095986A (ko) | 2007-10-01 |
JP5240899B2 (ja) | 2013-07-17 |
EA012505B1 (ru) | 2009-10-30 |
IL183919A0 (en) | 2007-10-31 |
AU2006204454A1 (en) | 2006-07-13 |
AU2006204454B2 (en) | 2011-11-10 |
CN101103033A (zh) | 2008-01-09 |
EP1836207B1 (en) | 2012-10-10 |
CA2592007A1 (en) | 2006-07-13 |
ES2397080T3 (es) | 2013-03-04 |
US20080312225A1 (en) | 2008-12-18 |
WO2006072615A2 (en) | 2006-07-13 |
NO20073921L (no) | 2007-07-26 |
JP2008526717A (ja) | 2008-07-24 |
US8106047B2 (en) | 2012-01-31 |
EA200701396A1 (ru) | 2007-12-28 |
IL183919A (en) | 2011-06-30 |
CA2592007C (en) | 2013-12-10 |
NZ555661A (en) | 2010-11-26 |
EP1836207A2 (en) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007008137A (es) | Triazoloftalazinas como inhibidores de pde2. | |
HK1115590A1 (en) | Triazolophthalazines | |
WO2006072612A3 (en) | Triazolophthalazines as pde2- inhibitors | |
HUS2100051I1 (hu) | Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére | |
TW200640924A (en) | VEGF-R2 inhibitors and methods | |
PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
PL1761520T3 (pl) | Inhibitory kinazy | |
EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
MX2010006143A (es) | Azolilmetiloxiranos, su uso y agentes que lo contienen. | |
MX2009008798A (es) | Derivados de iminipiridina y sus usos como microbicidas. | |
MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
EA201000494A1 (ru) | Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4 | |
EA200701707A1 (ru) | Пиразолопиримидины | |
UA85505C2 (en) | Kinase inhibitors | |
WO2009077471A3 (de) | Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel | |
TW200600499A (en) | Novel amido-substituted hydroxy-6-phenylphenanthridines | |
EA200801413A1 (ru) | Гетероциклические сетр ингибиторы | |
TW200700358A (en) | Organic compounds | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
MY154498A (en) | Pyrazolone derivatives as pde4 inhibitors | |
MX2008001541A (es) | Metodos para la preparacion de inhibidores de polimerasa del vhc. | |
EA200901179A1 (ru) | Замещённые тетрагидрохинолины | |
EA200702584A1 (ru) | Спиробензимидазолы как ингибиторы секреции соляной кислоты | |
EA200701626A1 (ru) | Новые 6-пиридилфенантридины |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
HC | Change of company name or juridical status |